Description of STENAMUPORIS (SR-9009) Capsules:
STENAMUPORIS (SR-9009) Capsules have proven effective in treating obesity, chronic obstructive pulmonary disease (COPD), congestive heart failure, and the deterioration of lean muscle mass associated with aging. In addition to these benefits, STENAMUPORIS has shown significant improvements in cardiorespiratory performance, making it valuable for overall cardiovascular health and endurance.
Composition of STENAMUPORIS (SR-9009) Capsules:
Each bottle contains 60 capsules, with each capsule delivering 10mg of Stenabolic (SR-9009).
Precaution of STENAMUPORIS (SR-9009) Capsules:
The use of SR-9009 may suppress clotting factors II, V, VII, and X, leading to an increased prothrombin time. Patients on high doses should regularly monitor their hemoglobin and hematocrit levels to detect any signs of polycythemia.
Side Effects of STENAMUPORIS (SR-9009) Capsules:
STENAMUPORIS (SR-9009) Capsules are contraindicated in women who are pregnant or may become pregnant, as it can cause fetal harm. If pregnancy occurs while using this product, the patient should be informed of the potential hazards to the fetus.
Storage:
Store STENAMUPORIS (SR-9009) Capsules at room temperature, away from heat and direct sunlight, to ensure product stability and effectiveness.
DISCLAIMER: The content on this website, including text, images, and audio, is for informational purposes only and should not replace professional medical advice or treatment. We do not recommend specific medications or offer medical consultations. When considering the use of STENAMUPORIS (SR-9009) Capsules by Denik Pharma, it’s important to weigh the potential side effects and health risks. Consultation with a healthcare provider or sports medicine specialist is strongly recommended before use.
